Cancer Treatment Group Bourbonnais, IL - 60914

Cancer Treatment Group is categorized under Internal Medicine Doctors in Bourbonnais, IL and active since 2009.

Cancer Treatment Group was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Robert T Woodburn at the company’s single location by writing to 100 Provena Way, Bourbonnais, Illinois IL 60914 or by phoning (815) 937-2460. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cancer Treatment Group
Contact Person: Robert T Woodburn
Address: 100 Provena Way, Bourbonnais, Illinois 60914
Phone Number: (815) 937-2460
Website Address: cancertreatmentgroup.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Cancer Treatment Group was started in 2009 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Robert T Woodburn for inquiries that concern Cancer Treatment Group by calling the company number (815) 937-2460, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Treatment Group can be found at the coordinates 41.183167,-87.875164 as well as the street address 100 Provena Way in Bourbonnais, Illinois 60914.

For its online presence, you may visit Cancer Treatment Group’s website at cancertreatmentgroup.com and engage with its social media outlets through on Twitter and on Facebook.